EDGAR Filing Documents for 0001104659-24-024044

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

SEC Accession No. 0001104659-24-024044

Filing Date

2024-02-14

Accepted

2024-02-14 17:08:35

Documents

Group Members

D. E. SHAW & CO., L.L.C.D. E. SHAW VALENCE PORTFOLIOS, L.L.C.DAVID E. SHAW

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13G/A	tm245263d15_sc13ga.htm	SC 13G/A	68252
2	EXHIBIT 1	tm245263d15_ex1.htm	EX-99.1	6035
3	EXHIBIT 2	tm245263d15_ex2.htm	EX-99.2	5981
4	EXHIBIT 3	tm245263d15_ex3.htm	EX-99.3	5892
	Complete submission text file	0001104659-24-024044.txt		88063

Mailing Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036

Business Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036 2124780000

D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

IRS No.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037

Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400

Ambrx Biopharma, Inc. (Subject) CIK: 0001990550 (see all company filings)

IRS No.: 932892120 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94206 | Film No.: 24640382
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)